VetSheet

Olsalazine

5-aminosalicylic acid dimer

Reviewed by the VetSheet Veterinary TeamUpdated Apr 5, 2026Evidence-based veterinary reference

10-20 mg/kgPOΒ· q12h
β€” πŸ•

Doses are a clinical reference for licensed veterinary professionals. Always confirm against the current label and the individual patient.

Dosing by species

🌎 NA β€” North America🌍 EU β€” Europe

Dogs

IndicationDoseRouteFrequencyDurationRegion
All uses (Management of colitis)10-20 mg/kgPOq12hβ€”πŸŒ EU

Doses are a clinical reference for licensed veterinary professionals. Always confirm against the current label and the individual patient.

Recording this consult? VetSheet's AI writes the drug, dose and duration straight into a structured visit note.See how VetSheet works

Overview

Olsalazine is a dimer of ​5-aminosalicylic acid (5-ASA)​ used primarily for the management of colitis, particularly in patients who are sensitive to sulfasalazine.

​Clinical Warning:​ Although the incidence of keratoconjunctivitis sicca (KCS) is much lower than with sulfasalazine, it remains a potential risk. Periodic Schirmer tear tests should be performed during therapy.

Mechanism of action

Olsalazine is a prodrug that is cleaved by colonic bacteria β†’ releases free 5-ASA β†’ exerts a local anti-inflammatory effect directly on the colonic mucosa.

Safety & warnings

Contraindications

  • Patients sensitive to salicylates

Adverse effects

  • Keratoconjunctivitis sicca (dry eye)

Precautions

Normal precautions should be observed. Monitor tear production periodically due to the risk of keratoconjunctivitis sicca.

Drug interactions

NSAIDsModerate

Activity will be potentiated by administration of other NSAIDs

Monitoring

  • Schirmer tear tests (periodic)
  • Clinical response (resolution of colitis signs)

Pharmacokinetics

Absorption

Acts locally in the colon after cleavage.

Metabolism

Cleaved by colonic bacteria into free 5-aminosalicylic acid (5-ASA).

Overdose

No specific information available. Overdose may exacerbate gastrointestinal signs or increase the risk of salicylate toxicity.

Available products

Formulations

  • 250 mg capsule
  • 500 mg tablet

Human-labeled

  • 250 mg capsule
  • 500 mg tablet

Regulatory status

European Unionβœ“ ApprovedPrescription onlyEMA

Human authorized product used off-label under the cascade.

United Kingdomβœ“ ApprovedPrescription onlyVMD

POM (Prescription Only Medicine). Human authorized product used off-label.

No regulatory data for: πŸ‡ΊπŸ‡Έ US Β· πŸ‡­πŸ‡° HK Β· πŸ‡ΉπŸ‡Ό TW Β· πŸ‡―πŸ‡΅ JP Β· πŸ‡°πŸ‡· KR Β· πŸ‡¦πŸ‡Ί AU

Storage & stability

Store at room temperature. Normal precautions apply.

Client information

Administer this medication exactly as directed by your veterinarian. ​Do not give your pet any other pain relief or anti-inflammatory medications (like NSAIDs)​ without consulting your vet. Watch your pet's eyes closely; if you notice squinting, redness, or thick eye discharge, contact your veterinarian immediately as this drug can occasionally cause 'dry eye'.

VetSheet drug reference is intended for licensed veterinary professionals as a clinical decision-support aid, not a substitute for professional judgement or the manufacturer’s current label.